[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Springer Nature Link
Log in

Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

There has been a considerable interest in the identification of natural plant foods for developing effective agents against cancer. Thus, the anti-tumour effects of oregano in the in vivo and in vitro breast cancer model were evaluated.

Methods

Lyophilized oregano (ORE) was administered at two concentrations of 0.3 and 3 % through diet. The experiment was terminated 14 weeks after carcinogen administration. At autopsy, mammary tumours were removed and prepared for histopathological and immunohistochemical analysis. Moreover, in vitro evaluation in MCF-7 cells was carried out.

Results

Low-dose ORE suppressed tumour frequency by 55.5 %, tumour incidence by 44 %, and tumour volume by 44.5 % compared to control animals. Analysis of rat tumour cells showed Ki67, VEGFR-2, CD24, and EpCAM expression decrease and caspase-3 expression increase after low-dose ORE treatment. High-dose ORE lengthened tumour latency by 12.5 days; moreover, Bcl-2, VEGFR-2, CD24, and EpCAM expression decrease and caspase-3 expression increase in carcinoma cells were observed. Histopathological analysis revealed a decrease in the ratio of high-/low-grade carcinomas in both treated groups. In vitro studies showed that ORE decreased survival and proliferation of MCF-7 cells. In ORE-treated MCF-7 cells, an increase in cells expressing sub-G 0/G 1 DNA content and an increase in the percentage of annexin V/PI positive MCF-7 cells were observed. In vitro, both caspase-dependent and possible non-caspase-dependent apoptotic pathways were found. The deactivation of anti-apoptotic activity of Bcl-2, a decrease in mitochondrial membrane potential, and the activation of mitochondrial apoptosis pathway were observed in the ORE-treated MCF-7 cells.

Conclusions

Our results demonstrate, for the first time, a distinct tumour-suppressive effect of oregano in the breast cancer model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

AIF:

Apoptosis-inducing factor

ALDH:

Aldehyde dehydrogenase

BrdU:

5-Bromo-20-deoxyuridine

CSCs:

Cancer stem cells

FCM:

Flow cytometry analysis

HDL:

High-density lipoprotein

HG:

High grade

EpCAM:

Epithelial cellular adhesion molecule

LDL:

Low-density lipoprotein

LG:

Low grade

LOQ:

Limit of quantification

MCF-7:

Human adenocarcinoma cell line, oestrogen receptor positive

NMU:

N-methyl-N-nitrosourea

ORE 0.3/ORE 3:

Experimental group with dietary administered oregano in a concentration of 0.3 and 3 %

ORE:

Oregano

VEGF:

Vascular endothelial growth factor

VEGFR-2:

Vascular endothelial growth factor receptor-2

VLDL:

Very low-density lipoprotein

References

  1. Liu RH (2013) Dietary bioactive compounds and their health implications. J Food Sci 78:A18–A25

    Article  CAS  Google Scholar 

  2. Yiannakopoulou ECH (2014) Effect of green tea catechins on breast carcinogenesis: a systematic review of in vitro and in vivo experimental studies. Eur J Cancer Prev 3:84–89

    Article  Google Scholar 

  3. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR Jr, Scrafford CG et al (2008) Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women’s Health Study. Int J Cancer 23:664–671

    Article  Google Scholar 

  4. Kang HB, Zhang YF, Yang JD, Lu KL (2012) Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev 13:995–998

    Article  Google Scholar 

  5. Zhang Y, Li Q, Ge Y, Chen Y, Chen J, Dong Y, Shi W (2013) Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells. Phytother Res 27:397–403

    Article  CAS  Google Scholar 

  6. Ma H, Lai F, Xie H, Wang J, Wang H (2008) Involvement of the Bcl-2 family members in Pinus massoniana bark extract induced apoptosis in HeLa cells. Phytother Res 22:1472–1476

    Article  Google Scholar 

  7. Garvin S, Ollinger K, Dabrosin C (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231:113–122

    Article  CAS  Google Scholar 

  8. Zhang XL, Guo YS, Wang CH, Li GQ, Xu JJ, Chung HY et al (2014) Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities. Food Chem 152:300–306

    Article  CAS  Google Scholar 

  9. Srihari T, Balasubramaniyan V, Nalini N (2008) Role of oregano on bacterial enzymes in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis. Can J Physiol Pharmacol 86:667–674

    Article  CAS  Google Scholar 

  10. Begnini KR, Nedel F, Lund RG, Carvalho PH, Rodrigues MR, Beira FT, Del-Pino FA (2014) Composition and antiproliferative effect of essential oil of Origanum vulgare against tumor cell lines. J Med Food 17:1129–1133

    Article  CAS  Google Scholar 

  11. Berrington D, Lall N (2012) Anticancer activity of certain herbs and spices on the cervical epithelial carcinoma (HeLa) cell line. Evid Based Complement Alternat Med 2012:564927

    Article  Google Scholar 

  12. Savini I, Arnone R, Catani MV, Avigliano L (2009) Origanum vulgare induces apoptosis in human colon cancer CaCo2 cells. Nutr Cancer 61:381–389

    Article  CAS  Google Scholar 

  13. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M (2008) Cancer stem cell markers in common cancers—therapeutic implications. Trends Mol Med 14:450–460

    Article  CAS  Google Scholar 

  14. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 16:876–887

    Article  CAS  Google Scholar 

  15. Soltanian S, Matin MM (2011) Cancer stem cells and cancer therapy. Tumour Biol 32:425–440

    Article  Google Scholar 

  16. Scarpa ES, Ninfali P (2015) Phytochemicals as innovative therapeutic tools against cancer stem cells. Int J Mol Sci 16:15727–15742

    Article  CAS  Google Scholar 

  17. de Beça FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, Schmitt F (2013) Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol 66:187–191

    Article  Google Scholar 

  18. Ito M, Shien T, Omori M, Mizoo T, Iwamoto T, Nogami T et al (2015) Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor. Breast Cancer [Epub ahead of print]

  19. Anwar TE, Kleer CG (2013) Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer. Hum Pathol 44:1457–1464

    Article  Google Scholar 

  20. Chekhun SV, Zadvorny TV, Tymovska YO, Anikusko MF, Novak OE, Polishchuk LZ (2015) CD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes. Exp Oncol 37:58–63

    CAS  Google Scholar 

  21. Soysal SD, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G et al (2013) EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer. Br J Cancer 108:1480–1487

    Article  CAS  Google Scholar 

  22. Siddiqui JA, Singh A, Chagtoo M, Singh N, Godbole MM, Chakravarti B (2015) Phytochemicals for breast cancer therapy: current status and future implications. Curr Cancer Drug Targets 15:116–135

    Article  CAS  Google Scholar 

  23. Gottardis MM, Jordan VC (1987) Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 47:4020–4024

    CAS  Google Scholar 

  24. Russo J, Russo IH (2000) Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5:187–200

    Article  CAS  Google Scholar 

  25. Kubatka P, Kapinová A, Kružliak P, Kello M, Výbohová D, Kajo K et al (2015) Antineoplastic effects of Chlorella pyrenoidosa in the breast cancer model. Nutrition 31:560–569

    Article  CAS  Google Scholar 

  26. Kubatka P, Kapinová A, Kello M, Kruzliak P, Kajo K, Výbohová D et al (2015) Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. Eur J Nutr [Epub ahead of print]

  27. Mylona E, Nomikos A, Alexandrou P, Giannopoulou I, Keramopoulos A, Nakopoulou L (2007) Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression. Histol Histopathol 22:825–835

    CAS  Google Scholar 

  28. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  CAS  Google Scholar 

  29. Fialová S, Slobodníková L, Veizerová L, Grančai D (2015) Lycopus europaeus: phenolic fingerprint, antioxidant activity and antimicrobial effect on clinical Staphylococcus aureus strains. Nat Prod Res 29:2271–2274

    Article  Google Scholar 

  30. Kisková T, Jendželovský R, Rentsen E, Maier-Salamon A, Kokošová N, Papčová Z et al (2014) Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats. Eur J Cancer Prev 23:506–513

    Article  Google Scholar 

  31. Al Dhaheri Y, Eid A, AbuQamar S, Attoub S, Khasawneh M, Aiche G et al (2013) Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53. PLoS ONE 8(2):e56649

    Article  CAS  Google Scholar 

  32. Martins N, Barros L, Santos-Buelga C, Henriques M, Silva S, Ferreira IC (2014) Decoction, infusion and hydroalcoholic extract of Origanum vulgare L.: different performances regarding bioactivity and phenolic compounds. Food Chem 158:73–80

    Article  CAS  Google Scholar 

  33. Hossain MB, Rai DK, Brunton NP, Martin-Diana AB, Barry-Ryan C (2010) Characterization of phenolic composition in Lamiaceae spices by LC-ESI-MS/MS. J Agric Food Chem 58:10576–10581

    Article  CAS  Google Scholar 

  34. Kisková T, Ekmekcioglu C, Garajová M, Orendas P, Bojková B, Bobrov N et al (2012) A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Eur J Cancer Prev 21:163–170

    Article  Google Scholar 

  35. Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276:7320–7326

    Article  CAS  Google Scholar 

  36. Zhang J, Park HS, Kim JA, Hong GE, Nagappan A, Park KI, Kim GS (2014) Flavonoids identified from korean Scutellaria baicalensis induce apoptosis by ROS generation and caspase activation on human fibrosarcoma cells. Am J Chinese Med 42:465–483

    Article  CAS  Google Scholar 

  37. Oh SB, Hwang ChJ, Song SY, Jung YY, Yun HM, Sok CH et al (2014) Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3. Cancer Lett 353:95–103

    Article  CAS  Google Scholar 

  38. Kim JA, Kim DH, Hossain MA, Kim MY, Sung B, Yoon JH et al (2014) HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells. Int J Oncol 44:473–480

    CAS  Google Scholar 

  39. Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR et al (2010) Cancer prevention with natural compounds. Semin Oncol 37:258–281

    Article  CAS  Google Scholar 

  40. Mehta RG, Murillo G, Naithani R, Peng X (2010) Cancer chemoprevention by natural products: how far have we come? Pharm Res 27:950–961

    Article  CAS  Google Scholar 

  41. Cserni G, Voeroes A, Liepniece-Karele I, Bianchi S, Vezzosi V, Grabau D et al (2014) Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values. Breast 23:259–263

    Article  Google Scholar 

  42. Dean M (2005) Cancer stem cells: implications for cancer causation and therapy resistance. Discov Med 5:278–282

    Google Scholar 

  43. Rennó AL, Alves-Júnior MJ, Rocha RM, De Souza PC, de Souza VB, Jampietro J et al (2015) Decreased expression of stem cell markers by simvastatin in 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer. Toxicol Pathol 43:400–410

    Article  Google Scholar 

  44. Gao J, Liu X, Yang F, Liu T, Yan Q, Yang X (2015) By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis. Oncotarget 6:27187–27198

    Article  Google Scholar 

  45. Wu CH, Hong BH, Ho CT, Yen GC (2015) Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene. J Agric Food Chem 63:2432–2441

    Article  CAS  Google Scholar 

  46. Ouhtit A, Gaur RL, Abdraboh M, Ireland SK, Rao PN, Raj SG et al (2013) Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action. J Cancer 4:703–715

    Article  CAS  Google Scholar 

  47. Shelef LA (1983) Antimicrobial effects of spices. J Food Saf 6:29–44

    Article  Google Scholar 

  48. Mills E, Ernst E, Singh R, Ross C, Wilson K (2003) Health food store recommendations: implications for breast cancer patients. Breast Cancer Res 5:170–174

    Article  Google Scholar 

  49. Kaefer CM, Milner JA (2008) The role of herbs and spices in cancer prevention. J Nutr Biochem 19:347–361

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Scientific Grant Agency of the Ministry of Education of the Slovak Republic under the Contract No. VEGA 1/0108/16 and 1/0290/16 and by the Slovak Research and Development Agency under the Contract Nos. APVV-0325-07 and APVV-0550-11. This work was supported by the Grant “Martin Biomedical Centre” (ITMS: 26220220187), “Competence center for research and development in diagnosis and therapy”, code: 26220220153, and the Grant FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123), both projects co-funded from EU sources and European Regional Development Fund. This study was also supported by the project Medicínsky univerzitný park v Košiciach (MediPark, Košice) ITMS:26220220185 supported by Operational Programme Research and Development (OP VaV-2012/2.2/08-RO) (Contract No. OPVaV/12/2013). We thank to Eva Jakubovičová, Agáta Rešetárová, and Margaréta Kondeková for technical support.

Author information

Authors and Affiliations

  1. Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 4, 03601, Martin, Slovakia

    Peter Kubatka & Martin Péč

  2. Department of Pharmacology, Faculty of Medicine, P. J. Šafárik University, Kosice, Slovakia

    Martin Kello & Ján Mojžiš

  3. Department of Pathology, Slovak Medical University and St. Elisabeth Oncology Institute, Bratislava, Slovakia

    Karol Kajo

  4. Laboratory of Structural Biology and Proteomics, Central Laboratories, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr. 1946/1, 612 42, Brno, Czech Republic

    Peter Kruzliak

  5. Department of Anatomy, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia

    Desanka Výbohová

  6. Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia

    Marián Adamkov

  7. Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia

    Silvia Fialová & Daniel Grančai

  8. Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Toxicological and Antidoping Center, Comenius University in Bratislava, Bratislava, Slovakia

    Lucia Veizerová

  9. The Centre for Chronic Disease Prevention and Management (CCDPM), College of Health and Biomedicine, Victoria University, Melbourne, VIC, Australia

    Anthony Zulli

  10. Clinic of Stomatology and Maxillofacial Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia

    Dagmar Statelová

  11. Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar, Qatar Foundation – Education City, Doha, Qatar

    Dietrich Büsselberg

Authors
  1. Peter Kubatka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Kello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karol Kajo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Kruzliak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Desanka Výbohová
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ján Mojžiš
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marián Adamkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Silvia Fialová
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lucia Veizerová
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anthony Zulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Martin Péč
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Dagmar Statelová
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Daniel Grančai
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Dietrich Büsselberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Peter Kubatka, Peter Kruzliak or Martin Péč.

Ethics declarations

Conflict of interest

The authors state that there are no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kubatka, P., Kello, M., Kajo, K. et al. Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur J Nutr 56, 1303–1316 (2017). https://doi.org/10.1007/s00394-016-1181-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-016-1181-5

Keywords

Search

Navigation